Institutional Ownership
Mink Therapeutics Inc
CUSIP 603693201COM NEWINKTQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
20
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 17.3K | $182.7K |
| 2 | Longbow Finance SA | 16.7K | $175.5K |
| 3 | Ubs Group AG | 15.2K | $160.1K |
| 4 | Blackrock, Inc. | 6.2K | $65.3K |
| 5 | Steward Partners Investment Advisory, LLC | 2.0K | $21.1K |
| 6 | Annis Gardner Whiting Capital Advisors, LLC | 200 | $2.1K |
| 7 | Tower Research Capital LLC (Trc) | 156 | $1.6K |
| 8 | Morgan Stanley | 104 | $1.1K |
| 9 | Citigroup Inc | 91 | $958 |
| 10 | Northwestern Mutual Wealth Management Co | 18 | $190 |